These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 25877164

  • 1. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S.
    Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 3. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P.
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [Abstract] [Full Text] [Related]

  • 4. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ, International Organization for the Study of Inflammatory Bowel Diseases.
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [Abstract] [Full Text] [Related]

  • 5. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J, Rojas-Feria M, Castro-Fernández M, Millán-Lorenzo M, Guerrero-Jiménez P, Romero-Gómez M.
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [Abstract] [Full Text] [Related]

  • 6. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G, Belgian Inflammatory Bowel Disease Research Group, North-Holland Gut Club.
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM.
    Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 9. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ.
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 11. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T, Ono Y, Matsui T, Hirai F, Yano Y, Takatsu N, Ninomiya K, Tsurumi K, Sato Y, Takahashi H, Ookado Y, Koga A, Kinjo K, Nagahama T, Hisabe T, Takaki Y, Yao K.
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [Abstract] [Full Text] [Related]

  • 12. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG, Nieminen U, Sipponen T, Turunen U, Arkkila P, Färkkilä M.
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [Abstract] [Full Text] [Related]

  • 13. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM.
    Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
    [Abstract] [Full Text] [Related]

  • 14. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A.
    BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458
    [Abstract] [Full Text] [Related]

  • 15. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease.
    Kierkus J, Dadalski M, Szymanska E, Oracz G, Wegner A, Gorczewska M, Szymanska S, Woynarowski M, Ryzko J.
    Eur J Gastroenterol Hepatol; 2012 May 12; 24(5):495-500. PubMed ID: 22387887
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 12; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 17. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S, Dahele A, Fennel J, Aitken S, Shand AG, Arnott ID, Satsangi J.
    Inflamm Bowel Dis; 2008 Jun 12; 14(6):756-62. PubMed ID: 18275071
    [Abstract] [Full Text] [Related]

  • 18. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.
    Gastroenterol Clin Biol; 2002 Jan 12; 26(1):17-22. PubMed ID: 11938035
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation.
    Murakami Y, Matsui T, Hirai F, Takatsu N, Takaki Y, Nagahama T, Hisabe T, Beppu T, Miyaoka M, Maki S, Takeichi M, Nishimura T, Ueki T, Yao K.
    Dig Endosc; 2010 Jan 12; 22(1):25-32. PubMed ID: 20078661
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.